Imodium Plus

Loperamide Hydrochloride and Dimeticone, the active ingredient in Imodium Plus, is an antidiarrheal and antifoaming presented as an oral tablet for oral use. It treats acute and travel‑related diarrhea as well as gas‑related discomfort in adults and children.

GNH USA supplies Imodium Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Plus is indicated for conditions affecting intestinal motility and gas accumulation. - Acute diarrhea: provides symptomatic relief by slowing gut transit. - Travelers' diarrhea: reduces stool frequency and urgency during travel‑related infections. - Chronic diarrhea: helps manage persistent loose stools in conditions such as IBS‑D. - Gas relief: alleviates abdominal bloating by reducing surface tension of gas bubbles.

Imodium Plus may cause a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Constipation: excessive slowing of bowel movements. - Nausea: mild stomach upset. - Abdominal cramps: intermittent discomfort. Serious or Rare Side Effects: - Severe constipation: risk of bowel obstruction. - Toxic megacolon: rare but life‑threatening colonic dilation. - Allergic reactions: rash, itching, swelling.

Before using Imodium Plus, consider the following precautions. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown; weigh benefits versus risks. - Age restrictions: not recommended for children under 2 years. - Medical conditions: avoid in patients with known intestinal obstruction or severe hepatic impairment. - Drug interactions: consult a healthcare professional before combining with other antidiarrheals or opioids. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Imodium Plus can interact with several medicines; review the categories below. Major Interactions (Avoid): - Concomitant use with other opioid agonists: may enhance central opioid effects. - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): increase loperamide plasma levels. - Anticholinergic agents: may exacerbate constipation. Moderate Interactions (Monitor Closely): - Other antidiarrheal agents (e.g., bismuth subsalicylate): may reduce overall efficacy. - Drugs that prolong QT interval: additive cardiac risk. - Herbal supplements containing senna or cascara: increase risk of bowel dysfunction.